|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
134,770,000 |
Market
Cap: |
23.97(B) |
Last
Volume: |
1,205,898 |
Avg
Vol: |
1,128,967 |
52
Week Range: |
$136.64 - $182.07 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 226 |
Guru Rank Value : 6.9 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Quest Diagnostics provides diagnostic information services. Co. is made up of two businesses: Diagnostic Information Services, which develops and delivers diagnostic information services, providing insights that allow and enable a range of customers, including patients, clinicians, hospitals, independent delivery networks (including hospital health systems), health plans, employers, accountable care organizations and direct contract entities; and Diagnostic Solutions, which includes Co.'s risk assessment services business, which provides solutions for insurers, and Co.'s healthcare information technology businesses, which provides solutions for healthcare providers.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
43,494 |
60,178 |
183,918 |
202,015 |
Total Sell Value |
$7,343,224 |
$10,204,939 |
$29,908,973 |
$32,217,992 |
Total People Sold |
3 |
7 |
8 |
8 |
Total Sell Transactions |
4 |
16 |
23 |
30 |
End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Gregg Vicky B |
Director |
|
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
18,138 |
|
- |
|
Pfeiffer Gary M |
Director |
|
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
30,669 |
|
- |
|
Lassiter Wright Iii |
Director |
|
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
9,037 |
|
- |
|
Ring Timothy M |
Director |
|
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
29,507 |
|
- |
|
Morrison Denise M |
Director |
|
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
10,742 |
|
- |
|
Main Timothy L |
Director |
|
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
26,297 |
|
- |
|
Carter Robert B |
Director |
|
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
2,685 |
|
- |
|
Diaz Luis |
Director |
|
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
4,054 |
|
- |
|
Doi Tracey |
Director |
|
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,203 |
6,490 |
|
- |
|
Delaney Mark E |
SVP & Chief Commercial Officer |
|
2025-05-13 |
4 |
AS |
$175.31 |
$153,221 |
D/D |
(874) |
7,498 |
|
2% |
|
Delaney Mark E |
SVP & Chief Commercial Officer |
|
2025-05-12 |
4 |
AS |
$175.72 |
$153,579 |
D/D |
(874) |
8,372 |
|
1% |
|
Delaney Mark E |
SVP & Chief Commercial Officer |
|
2025-04-21 |
4 |
A |
$164.42 |
$4,111 |
D/D |
25 |
9,246 |
|
- |
|
Gregg Vicky B |
Director |
|
2025-04-21 |
4 |
A |
$164.42 |
$11,181 |
D/D |
68 |
16,935 |
|
- |
|
Samad Samer Abdul |
Executive Vice President & CFO |
|
2025-04-21 |
4 |
A |
$164.42 |
$12,167 |
D/D |
74 |
26,451 |
|
- |
|
Plewman Patrick |
SVP for Diagnostic Services |
|
2025-04-21 |
4 |
A |
$164.42 |
$13,318 |
D/D |
81 |
21,087 |
|
- |
|
Kuppusamy Karthik |
SVP, Clinical Solutions |
|
2025-04-21 |
4 |
A |
$164.42 |
$4,439 |
D/D |
27 |
10,612 |
|
- |
|
Kuppusamy Karthik |
SVP, Clinical Solutions |
|
2025-04-02 |
4 |
AS |
$170.00 |
$434,350 |
D/D |
(2,555) |
10,575 |
|
6% |
|
Davis J. E. |
CEO and President |
|
2025-04-02 |
4 |
AS |
$167.86 |
$6,602,074 |
D/D |
(39,191) |
127,623 |
|
6% |
|
Plewman Patrick |
SVP for Diagnostic Services |
|
2025-03-26 |
4 |
D |
$166.71 |
$27,007 |
D/D |
(162) |
20,988 |
|
- |
|
Delaney Mark E |
SVP & Chief Commercial Officer |
|
2025-03-26 |
4 |
D |
$166.71 |
$42,678 |
D/D |
(256) |
9,221 |
|
- |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2025-03-17 |
4 |
AS |
$170.00 |
$789,310 |
D/D |
(4,643) |
38,117 |
|
3% |
|
Doherty Catherine T. |
EVP, Regional Businesses |
|
2025-03-05 |
4 |
AS |
$174.13 |
$935,078 |
D/D |
(5,370) |
68,068 |
|
3% |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2025-03-04 |
4 |
D |
$173.74 |
$678,628 |
D/D |
(3,906) |
42,760 |
|
- |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2025-03-04 |
4 |
A |
$173.74 |
$1,485,303 |
D/D |
8,549 |
46,666 |
|
- |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2025-03-04 |
4 |
AS |
$175.79 |
$104,068 |
D/D |
(592) |
38,117 |
|
2% |
|
802 Records found
|
|
Page 1 of 33 |
|
|